ARTICLE | Company News
AZN, CytImmune in cancer deal
December 28, 2012 12:48 AM UTC
AstraZeneca plc (LSE:AZN; NYSE:AZN) partnered with CytImmune Sciences Inc. (Rockville, Md.) to evaluate the feasibility of combining an undisclosed preclinical cancer compound from the pharma with Cyt...